Multicenter clinical trial of recombinant human insulin-like growth factor I in patients with acute renal failure

Raimund Hirschberg(The Lundquist Institute), Hans‐Peter Guler(University Hospital of Zurich), Pamela Lipsett(University of California, Los Angeles), David G. Warnock(University of Alabama at Birmingham), Mark Munger(University of Maryland, Baltimore), Robert P. Baughman(University of Cincinnati), Stephen Lowry(University of California, Los Angeles), Joel D. Kopple(UCLA Medical Center), Wade Mckeown(University of California, Los Angeles), Marilyn T. Haupt(Oregon Health & Science University), Timothy Albertson(The Ocean Cleanup), Michael H. O’Shea(University of California, Los Angeles), R Kaiser(University of California, Los Angeles), Brian J. Myers(University of California, Los Angeles), Michael H. Metzler(Washington University in St. Louis), Kathrine Haenftling(University of California, Los Angeles), Kenneth E. Wood(University of California, Los Angeles), Marilyn C. Pike(Bethesda Hospital), Warren R. Summer(Johns Hopkins University), Joseph P. Minei(Parkland Memorial Hospital), Raymond L. Hintz(Endocrine Society), William B. Capra(University of California, Los Angeles), H. Hank Simms(University of California, Los Angeles), John Conger(University of California, Los Angeles), M. Murray(University of California, Los Angeles), Ernest Benjamin(Mount Sinai Hospital), Gary P. Zaloga(University of California, Los Angeles)

Kidney International

June 1, 1999

Cited by 305

|Proceedings of the National Academy of Sciences|2013|3k

|Circulation|2012|2.4k

|Journal of the American College of Cardiology|2012|1.6k

|New England Journal of Medicine|1996|1.3k

|Critical Care Medicine|1997|863

Related Papers